RxSight Income Statement (2020-2026) | RXST

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
4.90M5.79M8.43M8.94M11.36M12.62M16.09M17.49M20.81M22.20M28.58M29.51M34.89M35.31M40.21M37.90M33.64M30.34M32.61M30.89M
Cost of Revenue (Quarter)
5.71M4.45M5.56M5.18M6.57M7.26M8.67M7.12M8.79M8.47M10.93M8.83M10.64M10.09M11.43M9.57M8.45M6.11M7.34M7.39M
Gross Profit (Quarter)
-0.81M1.34M2.87M3.76M4.79M5.36M7.42M10.37M12.02M13.73M17.65M20.68M24.25M25.22M28.79M28.33M25.19M24.23M25.26M23.50M
Operating items
Research & Development (Quarter)
6.56M5.38M5.92M6.72M6.19M6.39M6.68M7.21M7.40M7.10M7.34M8.03M8.29M8.84M9.21M10.37M10.22M9.06M8.90M9.47M
Selling, General & Administrative (Quarter)
6.50M9.08M11.62M13.62M14.39M14.93M15.73M16.25M18.24M19.14M21.16M23.32M24.29M25.61M28.21M28.64M28.98M27.34M27.70M31.86M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
13.06M14.45M17.53M20.34M20.58M21.31M22.41M23.46M25.64M26.24M28.51M31.36M32.58M34.45M37.42M39.00M39.19M36.41M36.60M41.33M
Operating Income (Quarter)
-13.88M-13.11M-14.66M-16.58M-15.79M-15.96M-14.99M-13.10M-13.62M-12.51M29.03M-10.67M-8.33M-9.23M22.48M-10.67M-14.00M-12.18M28.69M-17.83M
EBIT (Quarter)
-13.88M-13.11M-14.66M-16.58M-15.79M-15.96M-14.99M-13.10M-13.62M-12.51M29.03M-10.67M-8.33M-9.23M22.48M-10.67M-14.00M-12.18M28.69M-17.83M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.05M0.20M0.44M0.84M1.39M1.78M1.75M1.66M1.58M2.28M2.91M2.71M2.51M2.25M2.38M2.19M1.95M
Other Non Operating Income (Quarter)
-0.36M-1.41M
Net income details
EBT (Quarter)
-13.47M-12.68M32.96M-17.59M-16.73M-16.82M-15.61M-13.21M-13.78M-12.40M-9.20M-9.09M-6.06M-6.33M21.48M-8.17M-11.75M-9.81M-9.15M-15.88M
Tax Provisions (Quarter)
0.00M-0.00M0.00M0.00M0.01M0.03M0.01M-0.02M0.01M0.02M0.01M0.01M0.02M0.03M0.01M0.01M0.01M
Profit After Tax (Quarter)
-13.48M-12.67M-15.73M-17.60M-16.73M-16.82M-15.61M-13.21M-13.80M-12.41M-9.18M-9.10M-6.08M-6.34M-5.94M-8.19M-11.79M-9.82M-9.15M-15.88M
Income from Continuing Operations (Quarter)
-13.48M-12.67M32.96M-17.60M-16.73M-16.82M-15.61M-13.21M-13.80M-12.41M-9.18M-9.10M-6.08M-6.34M21.47M-8.19M-11.79M-9.82M-9.15M-15.88M
Consolidated Net Income (Quarter)
-13.48M-12.67M32.96M-17.60M-16.73M-16.82M-15.61M-13.21M-13.80M-12.41M-9.18M-9.10M-6.08M-6.34M21.47M-8.19M-11.79M-9.82M-9.15M-15.88M
Income towards Parent Company (Quarter)
-13.48M-12.67M32.96M-17.60M-16.73M-16.82M-15.61M-13.21M-13.80M-12.41M-9.18M-9.10M-6.08M-6.34M21.47M-8.19M-11.79M-9.82M-9.15M-15.88M
Net Income towards Common Stockholders (Quarter)
-320.00-12.67M-15.73M-17.60M-16.73M-16.82M-15.61M-13.21M-13.80M-12.41M-9.18M-9.10M-6.08M-6.34M21.47M-8.19M-11.79M-9.82M-9.15M-15.88M
Additional items
EPS (Basic) (Quarter)
-3.28-0.680.09-0.64-0.61-0.61-0.55-0.42-0.40-0.35-0.25-0.25-0.16-0.16-0.15-0.20-0.29-0.24-0.22-0.38
EPS (Weighted Average and Diluted) (Quarter)
-3.53-0.680.09-0.64-0.61-0.61-0.55-0.42-0.40-0.35-0.25-0.25-0.16-0.16-0.15-0.20-0.29-0.24-0.22-0.38
Shares Outstanding (Weighted Average) (Quarter)
4.05M9.00M13.63M27.43M27.49M27.55M27.66M31.64M33.08M33.95M34.46M36.84M37.65M38.37M38.87M40.51M40.63M40.97M40.85M41.31M
Shares Outstanding (Diluted Average) (Quarter)
4.17M9.00M13.63M27.43M27.49M27.67M27.66M31.64M33.08M33.95M34.46M36.84M38.46M39.79M38.87M40.51M40.74M40.74M40.85M41.31M
EBITDA (Quarter)
-13.48M-12.68M-15.74M-17.67M-16.82M-16.77M-15.57M-13.13M-13.87M-12.40M-9.12M-9.15M-6.14M-5.70M-6.29M-8.34M-11.92M-9.64M-9.16M-16.00M
Interest Expenses (Quarter)
0.83M1.08M1.08M1.06M1.14M1.30M1.45M1.51M1.57M0.23M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.00M
Tax Rate (Quarter)
-0.02%0.03%0.01%-0.02%-0.03%-0.19%-0.10%0.20%-0.10%-0.26%-0.21%0.06%-0.22%-0.27%-0.10%-0.05%-0.04%